The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs

被引:11
|
作者
Nicze, Michal [1 ]
Borowka, Maciej [1 ]
Dec, Adrianna [1 ]
Niemiec, Aleksandra [1 ]
Buldak, Lukasz [1 ]
Okopien, Boguslaw [1 ]
机构
[1] Med Univ Silesia, Fac Med Sci, Dept Internal Med & Clin Pharmacol, Medykow 18, PL-40752 Katowice, Poland
关键词
peptide- and protein-based drug; oral drug absorption; permeation enhancers; hydrogels; microneedles; semaglutide; octreotide; desmopressin; cyclosporine; CELL-PENETRATING PEPTIDES; CYCLOSPORINE-A; IN-VITRO; CARDIOVASCULAR OUTCOMES; GASTROINTESTINAL MUCUS; INTESTINAL-ABSORPTION; TRYPSIN-INHIBITOR; TIGHT JUNCTIONS; HUMAN INSULIN; NANOPARTICLES;
D O I
10.3390/ijms25020815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drugs based on peptides and proteins (PPs) have been widely used in medicine, beginning with insulin therapy in patients with diabetes mellitus over a century ago. Although the oral route of drug administration is the preferred one by the vast majority of patients and improves compliance, medications of this kind due to their specific chemical structure are typically delivered parenterally, which ensures optimal bioavailability. In order to overcome issues connected with oral absorption of PPs such as their instability depending on digestive enzymes and pH changes in the gastrointestinal (GI) system on the one hand, but also their limited permeability across physiological barriers (mucus and epithelium) on the other hand, scientists have been strenuously searching for novel delivery methods enabling peptide and protein drugs (PPDs) to be administered enterally. These include utilization of different nanoparticles, transport channels, substances enhancing permeation, chemical modifications, hydrogels, microneedles, microemulsion, proteolytic enzyme inhibitors, and cell-penetrating peptides, all of which are extensively discussed in this review. Furthermore, this article highlights oral PP therapeutics both previously used in therapy and currently available on the medical market.
引用
收藏
页数:29
相关论文
共 50 条
  • [21] A Peptide-Based Supramolecular Hydrogel for Controlled Delivery of Amine Drugs
    Wang, Youzhi
    Zhang, Yiming
    Li, Xinxin
    Li, Can
    Yang, Zhimou
    Wang, Ling
    CHEMISTRY-AN ASIAN JOURNAL, 2018, 13 (22) : 3460 - 3463
  • [22] Insights into current directions of protein and peptide-based hydrogel drug delivery systems for inflammation
    Bertilla, X. Janet
    Rupachandra, S.
    POLYMER BULLETIN, 2023, 80 (09) : 9409 - 9436
  • [23] Novel Drug Delivery System for Lipophilic Therapeutics of Small Molecule, Peptide-based and Protein drugs
    Hussain, Rohanah
    Siligardi, Giuliano
    CHIRALITY, 2010, 22 (1E) : E44 - E46
  • [24] Emerging trends in oral delivery of peptide and protein drugs
    Mahato, RI
    Narang, AS
    Thoma, L
    Miller, DD
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2003, 20 (2-3): : 153 - 214
  • [25] The Future of Peptide-based Drugs
    Craik, David J.
    Fairlie, David P.
    Liras, Spiros
    Price, David
    CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 81 (01) : 136 - 147
  • [26] Peptide-Based Antiviral Drugs
    Murugan, N. Arul
    Raja, K. Muruga Poopathi
    Saraswathi, N. T.
    ANTIVIRAL DRUG DISCOVERY AND DEVELOPMENT, 2021, 1322 : 261 - 284
  • [27] RGD PEPTIDE-BASED DELIVERY
    RUOSLAHTI, E
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 170 - 170
  • [28] Peptide-based gene delivery
    Mahato, RI
    Monera, OD
    Smith, LC
    Rolland, A
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 1999, 1 (02) : 226 - 243
  • [29] Peptide-based delivery to bone
    Aoki, Kazuhiro
    Alles, Neil
    Soysa, Niroshani
    Ohya, Keiichi
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (12) : 1220 - 1238
  • [30] Protein and peptide-based renal targeted drug delivery systems
    Lu, Jingyi
    Xu, Xiaoling
    Sun, Xuanrong
    Du, Yongzhong
    JOURNAL OF CONTROLLED RELEASE, 2024, 366 : 65 - 84